reference/20820284

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20820284

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	714
issn	0939-5555 1432-0584
issueIdentifier	5
pageRange	705-714
publicationName	Annals of Hematology
startingPage	705
bibliographicCitation	Goto N, Tsurumi H, Goto H, Shimomura YI, Kasahara S, Hara T, Yasuda I, Shimizu M, Murakami N, Yoshikawa T, Fukuno K, Takahashi T, Kito Y, Takami T, Moriwaki H. Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens. Ann Hematol. 2012 May;91(5):705–14. doi: 10.1007/s00277-011-1363-4. PMID: 22183251.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92dcf5ab7fe6dcb9734d1160a0ca5391 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2fa5c7b179ea36137929639ad6229d98 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87ab1f621069f58cf6993bc85dccfecd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb8120411d9b76e58790e8c746eb1e10 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d90a6c4ceeb9162c540b54e780d1e04 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1eafc70e37a14f0a437a681da29661e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a6586a9d8e0ebeaa4a8137aae7565e27 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e183ed285a833c968acda8804f5fc363 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4325587521259f798083650a3c72f871 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_790941ece03b6ee3779280371025c917 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6fd133a04ec4302a388fcf00e6618706 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3b308afb5c43024d490e5d193c25ea4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_caa7cb1e16a316ad705586aba12cb0a7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_25f97308e000be7ad017bbd5189ef8c1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e712a565bffe4445526600e74d6a541
date	2011-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/22183251 https://doi.org/10.1007/s00277-011-1363-4
isPartOf	https://portal.issn.org/resource/ISSN/0939-5555 https://portal.issn.org/resource/ISSN/1432-0584 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1088
language	English
source	https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/
title	Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens
discusses	http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0544940 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0244307 http://id.nlm.nih.gov/mesh/M0022676 http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0023684 http://id.nlm.nih.gov/mesh/M0573217
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3f5453e192e572cbc2bed32097c7aaaf http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9859 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128812924 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275

Total number of triples: 60.